vaccine confidence

Mary Woolley, President and CEO of Research!America, opened the American Association of Colleges of Pharmacy (AACP) annual meeting by leading a conversation on “Combating Anti-Science Thinking” with Georges C. Benjamin, MD , Executive Director of the American Public Health Association, and Bruce Gellin, MD , Chief of Global Public Health Strategy at the Rockefeller Foundation. The panelists addressed disturbing trends in anti-science thinking; the prevalence of misinformation and disinformation; and ongoing efforts within their organizations to address science skepticism, with emphasis on vaccine hesitancy. Here are a few highlights from their discussion, but you can also watch the entire...
According to a public opinion survey commissioned by Research!America Americans largely trust the work done by our nation’s scientists. Seven in 10 Americans believe that the work scientists do benefits all or most people in the United States and more than 80% believe that the work scientists do benefits them personally. Research institutions are among those that inspire the highest confidence, along with military, police, and small businesses. Doctors, nurses, scientists, and public health officials took the top four spots for professionals whom Americans feel confident will act in their best interest. More than ever, Americans recognize the importance of basic research in advancing...
A recent Research!America blog post discussed the issue of vaccine hesitancy as an obstacle to ensuring that enough U.S. residents receive a COVID-19 vaccine. However, vaccine hesitancy is far from the only barrier to achieving equitable vaccine distribution. Although recent surveys show that historically mistreated groups are somewhat less willing to take the vaccine, a majority of Americans across all racial and ethnic groups say they would take the vaccine if it were available to them today. In spite of this, white Americans are being vaccinated at far higher rates than Americans in other racial groups – rates that reflect more than just vaccine hesitancy. According to the most recent...
This is part one in a series of blog posts exploring COVID-19 vaccine hesitancy, other barriers to immunization, and possible solutions. As the COVID-19 vaccine rolls out across the U.S., one question on everyone’s mind is, “when do things go back to normal?” The answer depends largely on when most Americans will be vaccinated. And vaccine uptake depends on how confident people feel about receiving the vaccine. With a thorough-but-swift scientific review process, and rampant misinformation, many people are hesitant to accept a COVID-19 vaccine. Experts estimate that 70-90% of Americans will need to be vaccinated against COVID-19 before it is possible to return safely to normal activities...
Dear Research Advocate, As President Biden said yesterday during his inaugural address, “With unity, we can do great things. Important things.” Science has long been a unifier — for the public and policymakers alike — and, due to the pandemic, is more in the forefront now than in many, many years. Science is the right partner for “The hill we climb; If only we dare”, in the words of inaugural poet Amanda Gorman. Last week’s announcement of the elevation of the Office of Science and Technology Policy (OSTP) director to the President’s Cabinet was groundbreaking, placing science and technology at the table, in the most literal sense. The nomination of Dr. Eric Lander as Presidential Science...
The COVID-19 pandemic has had an unprecedented impact on the United States and the world, with extraordinary human tragedy and economic disruption. Since March 2, 2020, nearly 400,000 people in the United States have died of COVID-19 and more than 21 million cases have been identified. Over the next month, an estimated 820,000 to two million new cases are projected in the U.S. As COVID-19 cases continue to surge, the FDA’s authorization of the Pfizer and Moderna vaccines is a critical step towards immobilizing the spread of COVID-19. But ensuring a critical mass of people are vaccinated is essential in bringing an end to the pandemic. According to a recent JAMA article , the share of U.S...
Dear Research Advocate, Supplemental Funding Needs, Part 1 : President-elect Biden has indicated he will seek bipartisan support for a supplemental funding measure to address the urgent and ever-evolving needs created by this vicious and ongoing pandemic. Research!America has sent a letter to the President-elect with several supplemental funding requests, and we will follow up with a letter to Congressional leadership. Earlier this week we held an alliance member meeting with NIH Principal Deputy Director Dr. Larry Tabak and Deputy Director for Extramural Research Dr. Michael Lauer ( recording here ). Every minute of this meeting provided vital information on how the agency is struggling to...
With 2020 in our rearview mirror, we’re taking a look back at our 10 most popular blog posts (based on page views) for the year. The posts cover a wide range of topics including basic and clinical research, public health, clinical trials, and the impacts of COVID-19. We thank our distinguished group of guest bloggers including young researchers, academics, industry experts, public health professionals, and patient advocates as well as the staff here at Research!America who are united in support for stronger investments in research and innovation to combat diseases and build a safer, stronger, healthier nation. 1) Explained: How a COVID-19 Serology Test Works and Obstacles to its Use May 19...
Dear Research Advocate, Leadership Required : For so many of us, the events of the last 24 hours are difficult to fully comprehend. Our nation has experienced a profound shock to our democracy. The tragic overlay to this tumultuous time is that our nation faces an enemy that thrives on the very distrust, turmoil, and political gridlock we have been witnessing. COVID-19 has now killed more than 360,000 Americans — more lives lost in just ten months than the entire population of 99.7% of the cities and towns in this nation. In addition to assuring the peaceful transition of power to a new Administration, federal, state, and local lawmakers, and leaders from all sectors, can — and they must —...
Dear Research Advocate, Earlier this week, Congress passed a long-awaited legislative package containing FY21 funding and COVID-19 emergency dollars. However, President Trump has publicly criticized the bill and of this writing, it’s unclear whether he will sign it or seek changes. The current Continuing Resolution keeping the federal government open expires on December 28, 2020. Needless to say, we are closely monitoring the situation. Let’s look at the bill Congress approved: For FY21, it contains increases over the prior year of over $1 billion for NIH, $200 million for NSF, $125 million for the CDC, and $42 million for the FDA. Unfortunately, the Agency for Healthcare Research and...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient